Vycor Medical Inc (VYCO)

[kimokahu]

VYCO: STRONG BUY

We believe as the company executes that multiple will expand to 13x 2013 revenues,
resulting is a market capitalization of approximately $70M. With an assumed 950M average shares outstanding
this results in our 12-18 month target price of $0.05. Relative to the current price of $0.0195 our target price
represents >200% return in 12-18 months. We are initiating coverage of Vycor with a Strong Buy rating, and
believe it warrants consideration by any risk-tolerant, growth-seeking investor.